Background: Dermatitis herpetiformis (DH) is a rare autoimmune blistering disease characterized by pruritic papulovesicular eruptions. It can be differentiated from other vesiculobullous skin diseases by skin biopsy with direct immunofluorescence. DH is most often associated with gluten enteropathy (celiac disease) also an uncommon disease.

Case Presentation: We report a case of a 20-year-old male with a five-week history of multiple vesicles and bullae associated with fever and body malaise. Lesions were symmetrically found on the entire face, axillae, trunk, buttocks and lower extremities. Hematology revealed leukocytosis with neutrophilic predominance. Skin punch biopsy revealed subepidermal blister with neutrophilic predominance. A direct immunofluorescence (DIF) of the perilesional skin showed granular IgA staining at the tips of the dermal papillae, consistent of DH.

Treatment and Outcome: The patient was started with cloxacillin and mupirocin ointment for the infected skin lesions. Dapsone 100 mg daily was started with significant improvement of lesions after seven days. Endoscopy was suggested to investigate for gluten enteropathy, however patient did not consent. The patient was advised on gluten-free diet (GFD). Complete resolution of lesions with postinflamamtory hypo- and hyperpigmented scarring were noted after nine weeks of dapsone therapy.

Conclusion: Bullous skin lesions present as a great challenge to non-dermatologists, hence a thorough investigation was clearly of utmost importance in arriving at a diagnosis of DH in this case. Internists must be aware that skin lesions could provide clues of other internal diseases, such as in DH and gluten enteropathy. Treatment of DH can be as simple as diet modification and avoidance of gluten-containing food.

Keywords: Dermatitis Herpetiformis, Dermatology, Celiac Disease, Gluten Enteropathy, Dapsone  

1. Hull CM, Zone J. Dermatitis Herpetiformis and Linear IgA Bullous Dermatosis. In: Bolognia JL, Jorizo JL, Schaffer JV. Dermatology. Third edition. Elsevier; 31: 475-499; 32: 501-513.
2. Reunala T. Incidence of familial dermatitis herpetiformis. Br J Dermatology.1996; 134: 394-8.
3. Bolotin D, Petronic-Rosic P. Dermatitis herpetiformis: part I. Epidemiology, pathogenesis, and clinical presentation. Journal of the American Academy of Dermatology. 2011;64(6):1017–1024.
4. Smith JB, Tulloch JE, Meyer LJ, Zone JJ. The incidence and prevalence of dermatitis herpetiformis in Utah. Arch Dermatol. 1992;128:1608-10.
5. Sousa L, Bajanca R, Cabral J, Fiadeiro T. Dermatitis Herpetiformis: Should Direct Immunofluorescence Be the only diagnostic Criterion? Pedi Dermatol 2002;19(4):336-339.
6. Preisz K, Sárdy M, Horváth A. Immunoglobulin, complement and epidermal transglutaminase deposition in the cutaneous vessels in dermatitis herpetiformis. Journal of the European Academy of Dermatology and Venereology. 2005;19(1):74–79.
7. Ronagly A, Katz SI, Hall RS. Dermatitis Herpetiformis. In: Goldsmith L, Katz S, Gilchrest B, Paller A, Leffell D, Wolff K. Fitzpatrick’s Dermatology in General Medicine. 8th edition. New York: McGraw-Hill; 2008. P.642-648
8. Alonso-llamazares J, Gibson LE, Rogers RS. Clinical, pathologic and immunopathologic features of dermatitis herpetiformis: Review of the Mayo Clinic experience. International Journal of Dermatology. 2007;46(9):910–919.
9. Farrel RJ, Kelly CP. Celiac Sprue. N Engl J Med. 2002;346:180-8.
10. Fry L. Effect of gluten free-diet on dermatological, intestinal and hematological manifestations of dermatitis herpetiformis. Lancet. 1968; 1:557-561,.
11. Hervonen K, Vornanen M, Kautiainen H. Lymphoma in patients with dermatitis herpetiformis and their first degree-relatives. Br J Dermatol. 2005;49(52):82–86.
12. Vilijamaa J, Kaukinen K, Pukkala E. Malignancies and mortality in 47 patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study. Dig Liver Dis 2006;38:374–380.
13. Godkin A, Jewell D. The pathogenesis of Celiac disease. Gastroenterology. 1998;115:206-10.
14. Cardones ARG, Hall RP. Pathophysiology of dermatitis herpetiformis: A model for cutaneous manifestations of gastrointestinal inflammation. Dermatologic Clinics,. 2011; 29(3): 469–477.
15. Fry L. Clearance of skin lesions in dermatitis herpetiformis after gluten withdrawal. Lancet. 1973; 1: 288-291.
16. Hull CM, Liddle M, Hansen N. Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis. Br J Dermatol. 2008;159:120-4.
17. Duhring LA. Dermatitis herpitiformis. JAMA. 1893;3: 225.
18. Turchin I, Barankin B. Dermatitis herpetiformis and gluten-free diet. Dermatol Online J. 2005;11:6.
19. Sener O, Doganci L, Safali M. Severe dapsone hypersensitivity syndrome. J Invest Allergol Clin Immunol. 2006;16:268–270.